SDZNY

SDZNY

OTC

Sandoz Group AG

86.32

1.15(1.35%)
Volume

0.0M

Market Cap

$37.35B

P/E Ratio

43.06

EPS

$1.69


Price Chart

Price Alerts

No price alerts set. Add an alert to get notified!

Notify when price goes above $120.00
Notify when price goes above $180.00
Notify when price goes below $180.00

Key Financial Ratios

P/E Ratio

43.06

P/B Ratio

3.34

EPS

$1.69

ROE

7.76%

Profit Margin

8.24%

Operating Margin

15.38%

Peer Comparison

Compare TSM with similar companies in the sector

Company Price Change % P/E Market Cap D/E
BAYRY
Bayer AG
$11.90 -0.83% -11.02 $46.76B 1.44
FSNUF
Fresenius SE & Co. KGaA
$54.35 0.00 19.99 $30.61B 0.62
HLNCF
Haleon plc
$4.85 -0.51% 31.19 $43.23B 0.52
JDHIF
JD Health International Inc.
$6.15 -5.17% 24.90 $19.69B 0.01
OTSKF
Otsuka Holdings Co., Ltd.
$69.70 -3.48% 15.16 $36.81B 0.08
OTSKY
Otsuka Holdings Co., Ltd.
$33.12 -0.07% 15.16 $34.98B 0.08
RYLPF
Koninklijke Philips N.V.
$28.70 -0.65% 26.31 $27.30B 0.74
SDMHF
Sartorius Stedim Biotech S.A.
$220.20 7.41% 66.23 $21.42B 0.67
TEVJF
Teva Pharmaceutical Industries Limited
$28.36 0.00 25.63 $33.02B 2.20
TKPHF
Takeda Pharmaceutical Company Limited
$34.52 0.00 78.39 $54.53B 0.64

* Peer stocks are selected based on market capitalization and sector

Private Notes

Key Statistics

52 Week High

$94.15

52 Week Low

$38.06

Dividend

$0.73

Dividend Yield

1.00%

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.